344 related articles for article (PubMed ID: 27334854)
21. Novel therapeutic avenues in myeloma: changing the treatment paradigm.
Ghobrial J; Ghobrial IM; Mitsiades C; Leleu X; Hatjiharissi E; Moreau AS; Roccaro A; Schlossman R; Hideshima T; Anderson KC; Richardson P
Oncology (Williston Park); 2007 Jun; 21(7):785-92; discussion 798-800. PubMed ID: 17722741
[TBL] [Abstract][Full Text] [Related]
22. Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma.
Palumbo A; Sonneveld P
Expert Rev Hematol; 2015 Aug; 8(4):481-91. PubMed ID: 26070331
[TBL] [Abstract][Full Text] [Related]
23. Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma.
Neri P; Bahlis NJ
Curr Cancer Drug Targets; 2012 Sep; 12(7):776-96. PubMed ID: 22671924
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the management of multiple myeloma.
Munshi NC
Semin Hematol; 2004 Apr; 41(2 Suppl 4):21-6. PubMed ID: 15190512
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of effectiveness of novel therapies in multiple myeloma.
Bianchi G; Ghobrial IM
Leuk Lymphoma; 2013 Feb; 54(2):229-41. PubMed ID: 22897729
[TBL] [Abstract][Full Text] [Related]
26. New insights, recent advances, and current challenges in the biological treatment of multiple myeloma.
Vallet S; Podar K
Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S35-53. PubMed ID: 23768134
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of novel therapeutic approaches for multiple myeloma.
Hideshima T; Anderson KC
Nat Rev Cancer; 2002 Dec; 2(12):927-37. PubMed ID: 12459731
[TBL] [Abstract][Full Text] [Related]
28. The next generation of novel therapies for the management of relapsed multiple myeloma.
Gonsalves WI; Milani P; Derudas D; Buadi FK
Future Oncol; 2017 Jan; 13(1):63-75. PubMed ID: 27513456
[TBL] [Abstract][Full Text] [Related]
29. Lenalidomide in multiple myeloma.
Richardson PG; Mitsiades C; Hideshima T; Anderson KC
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1165-73. PubMed ID: 16925483
[TBL] [Abstract][Full Text] [Related]
30. Novel targeted therapies and combinations for the treatment of multiple myeloma.
Agarwal A; Mahadevan D
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):2-15. PubMed ID: 22882073
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the treatment of Multiple Myeloma.
Yasui H; Hideshima T; Richardson PG; Anderson KC
Curr Pharm Biotechnol; 2006 Oct; 7(5):381-93. PubMed ID: 17076653
[TBL] [Abstract][Full Text] [Related]
32. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
[TBL] [Abstract][Full Text] [Related]
33. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow microenvironment and the identification of new targets for myeloma therapy.
Podar K; Chauhan D; Anderson KC
Leukemia; 2009 Jan; 23(1):10-24. PubMed ID: 18843284
[TBL] [Abstract][Full Text] [Related]
35. Role of the bone marrow microenvironment in multiple myeloma.
Roodman GD
J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Pim kinases in multiple myeloma.
Keane NA; Reidy M; Natoni A; Raab MS; O'Dwyer M
Blood Cancer J; 2015 Jul; 5(7):e325. PubMed ID: 26186558
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for multiple myeloma.
Anderson KC
Semin Hematol; 2001 Jul; 38(3):286-94. PubMed ID: 11486317
[TBL] [Abstract][Full Text] [Related]
39. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions.
Anderson KC
Exp Hematol; 2007 Apr; 35(4 Suppl 1):155-62. PubMed ID: 17379101
[TBL] [Abstract][Full Text] [Related]
40. Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside.
Bruno B; Giaccone L; Rotta M; Anderson K; Boccadoro M
Leukemia; 2005 Oct; 19(10):1729-38. PubMed ID: 16094421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
